ROCHESTER, N.Y., Feb. 8, 2012 (GLOBE NEWSWIRE) -- NaturalNano, Inc. (OTCBB:NNAN) (http://www..naturalnano.com/">www.naturalnano.com) announced today that Fiabila S.A., a world leader in the manufacture of private label nail polish products, has placed its initial 2012 purchase orders for NaturalNano's Halloysite Natural Tube (HNT) as key component of a number of nail polish products sold in the USA and in Europe.
NaturalNano's Acting CEO& President James Wemett said, "These recent orders from Fiabila reflect their successful commercial results from their product line which incorporates HNT technology. Fiabila's current nail polish products containing HNT are currently being sold at the largest retailers in the USA, including Target, Wal-Mart, CVS and Walgreen's, and their market expansion of those lines into European Markets.
NaturalNano has recently signed a three year extension for an exclusive supply agreement and license with Fiabila for the use of HNT in nail-care products."
Pierre Miasnik, President of Fiabila, said, "It is relationships with innovative companies like NaturalNano that have been key to our overall success. We have been pleased with the commercial and technical results in the USA and now Europe."
About NaturalNano, Inc.
NaturalNano, Inc. (OTCBB:NNAN) is a materials science company focused on developing and commercializing advanced nanocomposites. The Company is focused on additive technologies and processes, including its proprietary Pleximer that adds value to industrial polymers, plastics and composites. NaturalNano holds and/or licenses 20 patents and applications relating to Halloysite, as well as proprietary know-how for its extraction and separation processes, compositions, and derivatives. http://www.naturalnano.com/">www.naturalnano.com
Cautionary Statement Regarding Forward-Looking Statements: Contains forward-looking statements regarding future events and future performance that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-K and quarterly reports on Form 10-Q filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.